Transdermal drug delivery patches for pain and CNS diseases
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
49
NCT03639571
Phase I Study to Assess Irritation, Sensitization and Adhesion of a Novel Ibuprofen 200 mg TEPI Medicated Plaster
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 9, 2018
Completion: Oct 25, 2018
NCT03694587
pK of a Novel 200 mg Ibuprofen Medicated Plaster
Start: Sep 25, 2018
Completion: Oct 18, 2018
Loading map...